Available in English and Spanish, this e-newsletter separates fact from fiction on over 40 heart topics by Texas Heart Medical Group's Dr. Stephanie Coulter.
Texas Heart Institute (THI) conducts research through clinical trials as part of our mission to improve heart health. The trials conducted at THI are designed to test the safety and effectiveness of innovative new treatments and medications for patients.
Heart and vascular disease remain the leading contributor to morbidity and mortality among both women and men. While the decrease in mortality among women is well documented, the decline still lags behind that of men, with an alarming tendency towards an increased mortality rate among younger women. REGISTER TODAY
Our progress would not be possible without our donor community. Help support our mission by giving today.
Houston, TX (February 11, 2021) – The Texas Heart Institute is pleased to announce that Dr. James Martin, Director of its...
Today more than 30 million patients suffer from painful inflammatory conditions. Prescription opioid pain relievers are commonly prescribed for these...
It is with great sadness that we inform you of the passing of THI’s President Emeritus, Dr. James T....
Houston, TX – August 24, 2020– Heart disease is the leading cause of death in both women and men in...
Technology co-invented by scientists at the Texas Heart Institute and 7 Hills Pharma received broad patent protection from the U.S....
Rice University partnered with the Texas Heart Institute (THI) to define the body’s response to their injectable hydrogels that are...
A promising molecular technology co-invented by scientists at the Texas Heart Institute and 7 Hills could soon enhance the effectiveness...
A promising technology invented at the Texas Heart Institute is one step closer to being tested in a clinical study...
Houston (October 8, 2019) — Texas Heart Institute is proud to announce Robert McNeil as the Administrative Director of the...
